Preparation and Bioavailability of Ibuprofen Suspension
Yuan Kai
Abstract
Yuan Kai
Abstract
Ibuprofen suspension was prepared with CMC-Na, sucrose and mannitol as excipients. The pharmacokinetics and bioavailability of ibuprofen suspension in 10 healthy volunteers were compared with ibuprofen tablets. The concentration of ibuprofen in serum was determined by HPLC. The major pharmacokinetics parameters of ibuprofen suspension and tablets were t max (0.790±0.360) h and ( 4.024 ±0.819) h, c max (22.28±3.68) μg/ml and (20.04±3.370) μg/ml, t 1/2 (2.020±0.270) h and ( 2.026 ± 0.265 ) h, respectively. The relative bioavailability of ibuprofen suspension was (91.46±10.59)%.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Ibuprofen suspension was prepared with CMC-Na, sucrose and mannitol as excipients. The pharmacokinetics and bioavailability of ibuprofen suspension in 10 healthy volunteers were compared with ibuprofen tablets. The concentration of ibuprofen in serum was determined by HPLC. The major pharmacokinetics parameters of ibuprofen suspension and tablets were t max (0.790±0.360) h and ( 4.024 ±0.819) h, c max (22.28±3.68) μg/ml and (20.04±3.370) μg/ml, t 1/2 (2.020±0.270) h and ( 2.026 ± 0.265 ) h, respectively. The relative bioavailability of ibuprofen suspension was (91.46±10.59)%.
Key concepts: Ibuprofen, Bioavailability, Chemistry, Chromatography, Pharmacokinetics, Suspension (topology), Mannitol, High-performance liquid chromatography